UCLA Downtown Los Angeles Primary & Specialty Care

Los Angeles, California 90017

1 studies enrolling now · 2 studies all time

What they study most

Urothelial Carcinoma

Studies at this site

• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
• Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 — Running, not enrolling